Empiri is a biotechnology firm that creates a tool to treat cancer by giving individualized drug response information ahead of treatments.
Empiri has raised $250K in total funding. The most recent round was Seed. The last funding was announced in May 2022.
Empiri's investors include Newchip Accelerator.
Empiri is headquartered in Houston, United States.
Empiri is a biotechnology firm that creates a tool to treat cancer by giving individualized drug response information ahead of treatments.
Empiri is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Empiri — Funding & Investors." VCBacked, May 25, 2022, https://www.vcbacked.co/company/empiri. Accessed September 13, 2026.
VCBacked. (2022). Empiri — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/empiri
{{cite web |title=Empiri — Funding & Investors |url=https://www.vcbacked.co/company/empiri |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated